A Safety and Efficacy Study of VI-0521 to Evaluate the Long Term Treatment of Obesity in Adults With Obesity-Related Co-Morbid Conditions. An Extension Study of Protocol OB-303 (NCT00553787)
Completed
Medpace, Inc.
Phase 3
2008-12-01
The purpose of this study is to evaluate the long-term safety and efficacy of VI-0521
compared to placebo for the treatment of overweight and obesity in adults who have completed
study OB-303 (NCT00553787) at selected study sites. This is an extension study of protocol
OB-303 (NCT00553787).
A Safety and Efficacy Study of VI-0521 to Evaluate the Long Term Treatment of Obesity in Adults With Obesity-Related Co-Morbid Conditions. An Extension Study of Protocol OB-303 (NCT00553787)
Completed
VIVUS, Inc.
Phase 3
2008-12-01
The purpose of this study is to evaluate the long-term safety and efficacy of VI-0521
compared to placebo for the treatment of overweight and obesity in adults who have completed
study OB-303 (NCT00553787) at selected study sites. This is an extension study of protocol
OB-303 (NCT00553787).
Peripheral Pharmacodynamics of Phentermine-Topiramate in Obese Patients
Completed
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase 4
2013-04-01
Our overall goal is to determine the effect of Phentermine and Topiramate ER on gastric
emptying, gastric accommodation, satiety, and satiation in obese participants.
Peripheral Pharmacodynamics of Phentermine-Topiramate in Obese Patients
Completed
Mayo Clinic
Phase 4
2013-04-01
Our overall goal is to determine the effect of Phentermine and Topiramate ER on gastric
emptying, gastric accommodation, satiety, and satiation in obese participants.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
